Prelude Therapeutics, Inc. (PRLD)

3.29 +0.43 (+15.04%) USD  |  NASDAQ  |  Feb 25, 16:00
3.17 -0.12 (-3.65%) After-Hours: 04:07
More

Prelude Therapeutics Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for PRLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
BioLife Solutions, Inc. Upgrade
Immunome, Inc. Upgrade
Incyte Corp. Upgrade
Aclaris Therapeutics, Inc. Upgrade
Relay Therapeutics, Inc. Upgrade